Successful treatment of plasma cell cheilitis with topical tacrolimus: report of two cases.

Abstract

Plasma cell cheilitis is an uncommon chronic inflammatory dermatitis that presents with flat to slightly elevated erosive erythematous plaques. It is histologically characterized by plasma cell infiltrates into the mucosa. Other than the lip, genital areas are often involved, which is called plasma cell balanitis or vulvitis. Plasma cell cheilitis is sometimes resistant to conventional topical corticosteroid therapy. Other choices include oral griseofulvin, topical cyclosporine, and intralesional corticosteroid injection, all of which occasionally fail to produce satisfactory results. Recent reports show that topical calcineurin inhibitors are effective for plasma cell cheilitis, balanitis, and vulvitis. However, there are so far only 2 reports of plasma cell cheilitis successfully treated with topical pimecrolimus and tacrolimus. We present herein two cases of plasma cell cheilitis, in which topical tacrolimus showed beneficial effects, suggesting that this immunomodulatory agent is a promising option for plasma cell cheilitis.

• Authors: Yuka Hanami, Yoshikazu Motoki, Toshiyuki Yamamoto
• Journal: Dermatology online journal (Dermatol Online J) Vol. 17 Issue 2 Pg. 6 (Feb 15 2011) ISSN: 1087-2108 [Electronic] United States
• PMID: 21382289 (Publication Type: Case Reports, Journal Article)

Chemical References

• Immunosuppressive Agents
• Tacrolimus

Topics

• Administration, Topical
• Aged
• Cheilitis (drug therapy, pathology)
• Humans
• Immunosuppressive Agents (administration & dosage, therapeutic use)
• Male
• Plasma Cells (pathology)
• Tacrolimus (administration & dosage, therapeutic use)